In a groundbreaking initiative, the National Institutes of Health (NIH) is spearheading a workshop titled “Artificial Intelligence in Precision Medicine for Diabetes and Other Chronic Diseases.” This event is set to explore the transformative potential of artificial intelligence (AI) and machine learning (ML) in advancing precision medicine, particularly for diabetes and chronic diseases.

The workshop seeks to unite biomedical researchers and AI/ML experts to tackle pressing challenges, identify crosscutting gaps, and seize opportunities in leveraging AI/ML technologies. The focus is on enhancing biomarker development, drug discovery, and diagnostics, ultimately paving the way for personalized healthcare solutions. Recent strides in AI/ML, including generative AI and Large Language Models, are poised to revolutionize biomedicine.

Organizing Committee
The event is organized by a distinguished committee, featuring external co-chairs such as Marcela Brissova from Vanderbilt University, Jeffrey Grethe from the University of California, San Diego, and Wei Wang from the University of California, Los Angeles. They are joined by notable members from the NIH, including Eric Brunskill, Ph.D., and Debbie Gipson, M.D., M.S.

Pre-workshop Speaker Series
A pre-workshop speaker series has been designed to stimulate discussions on AI’s intersection with biomedicine. The series is divided into two parts:

  1. The Bio-Behavioral Dimensions of Diabetes Heterogeneity: Featuring Dr. Yao Qin from the University of California, Santa Barbara, discussing “Data-driven Machine Learning and Closed-loop Diabetes Care,” and Dr. Ashu Sabharwal from Rice University on “Bio-behavioral Pathways in Diabetes.”
  2. Advances in AI and Applications in Biomedicine: Featuring Dr. James Zou from Stanford University, focusing on “AI Agents in Biomedicine,” and Dr. Eran Halperin from the University of California, Los Angeles, discussing “AI Challenges and Opportunities across Data Modalities in Medicine.”
Event Details
The workshop is a hybrid event, allowing both in-person and virtual participation. It will be held at the Neuroscience Center Building in Rockville, MD. Although registration closed on October 25, 2024, the event promises to be a pivotal moment in the integration of AI/ML in precision medicine.

For more information, interested parties can access the original article and additional resources such as the Pre-Workshop Webinar 1 Flyer and Pre-Workshop Webinar 2 Flyer.

Contact Information

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

Wendy Simpson’s Strategic Guide to Purpose-Driven Rebranding in Multifamily Real Estate

In the ever-evolving world of multifamily real estate, rebranding is more than just a cosmetic change—it's a strategic overhaul that can redefine a company's identity and purpose.

AI Trends Shaping Business in 2025 and Beyond

Generative AI is revolutionizing industries by transforming business processes, enhancing client interactions, and opening new development opportunities. The necessity of integrating advanced AI solutions is becoming apparent for companies aiming to maintain their edge in the market.

CRE Sector Eyes Optimism for 2025 Amid Rising Energy Costs

Amidst a backdrop of rising energy costs and office vacancies, the commercial real estate (CRE) sector is buzzing with optimism for 2025.

The Power of Real Estate Designations: Elevating Your Career

"In a field where competition is fierce, standing out is paramount. Designations serve as a testament to an individual's dedication and proficiency.”

Strategic Positioning in the Commercial Real Estate Market

As the world of commercial real estate continues to evolve, organizations are presented with a generational opportunity to strategically position themselves for future developments. According to the latest insights from Deloitte’s 2025 commercial real estate outlook, this is a pivotal moment for industry leaders to capitalize on emerging trends.